Cystatin C at AACC 2020

07. Dec 2020 | 5 min read

Cystatin C at AACC 2020

Meet us at #2020AACC Virtual Exhibit Hall 

For its fourth consecutive year, Gentian Diagnostics will be participating in the AACC Annual Scientific Meeting & Clinical Lab Expo. This year’s all-virtual event promises to deliver the same breadth of world-class scientific content that attendees of prior AACC meetings would expect, albeit with greater accessibility and flexibility.

We invite you to use promo code 26138E for a free virtual Clinical Lab Expo pass. Please note that you will need to be registered with the AACC (its free) to use the promo code.

Cystatin C - Superior Kidney Marker1

More than 4000 journal articles have been published on the clinical relevance of cystatin C since it was discovered as a marker of GFR in 1979 by Dr. Anders Grubb. The rising cost pressures faced by health systems has pushed cystatin C into the forefront of biomarkers that could reduce healthcare costs.

In light of this Gentian will be promoting its cystatin C assay during the 2020 AACC Scientific Meeting & Clinical Lab Expo. 25 years after the first automated assay for cystatin C was developed, Gentian emphasises the unique prognostic and diagnostic value of cystatin C as a marker that:

  • Is independent of muscle mass2-8
  • Estimates GFR without race-adjustment9
  • Correlates well with GFR within the “creatinine blind area”10
  • Identifies chronic kidney disease (CKD) earlier than creatinine-based eGFR11
  • Ensures safety and efficacy of medications with a narrow therapeutic index9,12

Visit us at our virtual booth #2020AACC

The virtual exhibit hall is open 24/7 from December 13th, 2020 to January 18th, 2021. You’ll be able to meet and chat live with the exhibitors during December 14th-17th 10 AM to 2 PM U.S. Central Time. Visit us during these opening hours or book a meeting in advance through 

AACC 2020 PETIA immunoassays

Gentian Cystatin C Immunoassay 

  • Particle-Enhanced Turbidimetric Immunoassay
  • With avian antibodies for reduced interference 
  • Can be applied on most automated platforms
  • ERM-DA471/IFCC standardised
  • FDA510 (k) cleared and CE-marked


Contact us now for more information


Cystatin C immunoassay brochure



  1. Dharnidharka VR et al. Am. J. Kidney Dis. 2002;40:221–226.
  2. KDIGO Guidelines 2012 published in Kidney International Supplements Vol3 Issue 1, Jan 2013.
  3. NCIC Clinical guideline (CG182) updated jan 2015 section 2.1
  4. Tangri N et al. Kidney Int 2011;79:471-7.
  5. Grubb A et al. eJIFCC 2017 Vol 28 NO4 pp 268-276.
  6. Bjork J et al. Pediatr Nephrol. 2019;34:1087–1098.
  7. Lesly A et al. N Engl J Med 2012;367:20–29.
  8. Schaeffner ES et al. Ann Intern Med 2012;157:471–481.
  9. Ebert N et al. Curr Opin Nephrol Hypertens. 2020;29(6):591-598.
  10. Lindström V. Low molecular mass proteins as markers for renal function and dialysis efficiency. Doctoral Dissertation, Lund University, 2013.
  11. Murty MS et al. Indian J Nephrol. 2013;23(3):180-183.
  12. Frazee E et al. Am J Kidney Dis. 2017;69(5):658-666.

You may also read

The value of calprotectin in COVID-19 highlighted at AACC 2020

Jan 14, 2021

The value of calprotectin in COVID-19 highlighted at AACC 2020

How can calprotectin support management of COVID-19 patients? As hospitals continue to navigate challenges of..

Cystatin C - recommended by KDIGO and NICE

Jan 07, 2021

Cystatin C - recommended by KDIGO and NICE

Cystatin C is superior biomarker of renal function1 and it is recommended by KDIGO2 and NICE3. Glomerular..